Symbols

Symbols

TELA

TELA

TELA Bio Receives $70M in Funding to Expand Soft-Tissue Reconstruction Solutions

Friday Nov 14, 2025

TELA Bio: Piper Sandler downgrades to Neutral, PT reduced to $1.25.

TELA Bio:Citizens Maintains Market Outperform, PT Down to $5 from $7

Thursday Nov 13, 2025

TELA Bio Q3 rev. $20.7mln, up 9% YoY; FY22 rev. guidance revised up.

TELA Bio Earnings Preview: What Investors Need to Know

TELA Bio Inc's Sales Strategy Drives Growth Amid Financial Challenges

TELA Bio Q3 Earnings Miss Revenue Estimates, Shares Down 62.3% YTD

TELA Bio Raises $13M Through Registered Direct Offering

TELA Bio Announces $13 Million Registered Direct Offering of Common Stock and Pre-Funded Warrants

TELA Bio Reports Q3 2025 Financial Results, Revenue Up 9% YoY and Upsizes Credit Facility to $70M.

Wednesday Nov 05, 2025

TELA Bio shares rise 20.93% premarket ahead of Q3 2025 earnings report and investor conference call.

TELA Bio shares surge 15.50% premarket ahead of Q3 2025 financial results announcement and earnings call on November 13.

Tuesday Nov 04, 2025

TELA Bio shares jump 11.38% intraday after appointing William Plovanic to its board.

TELA Bio reports Q3 2025 financial results on Nov. 13, 2025.

Tela Bio Adds William Plovanic to Board of Directors

Monday Nov 03, 2025

TELA Bio Appoints William Plovanic to Board of Directors, Enhancing Capital Markets Expertise and Operational Leadership

Thursday Oct 09, 2025

Tela Bio Expands Board with Addition of Betty Jo Rocchio

TELA Bio Appoints Betty Jo Rocchio to Board, Announces Departure of Lisa Colleran

TEL A Bio: Multiple Insiders Purchase Stock Amid Positive Outlook

Monday Sep 01, 2025

TELA Bio Experiences Record Revenue and Market Growth in Q2 Earnings Call